Hence, genetic evolution and the identification of mutations of the CaSR gene helped clinicians to distinguish FHH from other causes of HPT as reliable distinction is not always possible on clinical grounds. The gene discussed is CASR; the disease is familial hypocalciuric hypercalcemia.